Not applicableEnded earlyNCT04875871What this trial is testingParticle-based Partial Tumor Irradiation of Unresectable Bulky TumorsWho this might be right forCancer EBG MedAustron GmbH 13
Testing effectiveness (Phase 2)Study completedNCT02505269What this trial is testingBrentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Massachusetts General Hospital 34
Early research (Phase 1)Ended earlyNCT04168320What this trial is testingSBRT-based PArtial Tumor Irradiation of HYpoxic SegmentWho this might be right forBystander EffectAbscopal EffectUnresectable Malignant Solid Neoplasm+1 more Klinikum Klagenfurt am Wörthersee 30
Large-scale testing (Phase 3)Study completedNCT01313689What this trial is testingOfatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic LeukemiaWho this might be right forLeukaemia Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT00112931What this trial is testingRituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma University College, London 462
Testing effectiveness (Phase 2)UnknownNCT02194751What this trial is testingOncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular LymphomaWho this might be right forFollicular Lymphoma XEME Biopharma Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01132807What this trial is testingChemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 164
Testing effectiveness (Phase 2)Study completedNCT00070018What this trial is testingS0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 46
Testing effectiveness (Phase 2)UnknownNCT04866654What this trial is testingRadiation Free Chemotherapy for Early Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Medical University of Gdansk 160
Not applicableUnknownNCT01399931What this trial is testingDual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky LesionsWho this might be right forHodgkin's Lymphoma Ospedale Santa Croce-Carle Cuneo 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07437625What this trial is testingLesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic DiseaseWho this might be right forHigh-Burden Metastatic Solid Tumors Li Min 90
Testing effectiveness (Phase 2)Ended earlyNCT00490490What this trial is testingStudy of Bexxar <Tositumomab> Combined With External Beam Radiation TherapyWho this might be right forLymphoma, Non-Hodgkin Stanford University 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888402What this trial is testingInduction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLCWho this might be right forLocal Advanced Non-small Cell Lung Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Looking for participantsNCT07435376What this trial is testingIntra-lesional Tumor Boost for Bulky Cervical CancerWho this might be right forCervical CancerSquamous Cell Carcinoma of Cervix Seoul National University Bundang Hospital 17
Not applicableEnded earlyNCT04779489What this trial is testingCheckpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder CancerWho this might be right forBladder Cancer University of Texas Southwestern Medical Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07775040What this trial is testingSpatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II TrialWho this might be right forNon-Small Cell Lung Cancer Sichuan Cancer Hospital and Research Institute 43
Testing effectiveness (Phase 2)Study completedNCT01118026What this trial is testingResponse-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 101
Testing effectiveness (Phase 2)Study completedNCT00086801What this trial is testingCombination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 104
Not applicableWithdrawnNCT06390657What this trial is testingRadiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky TumorsWho this might be right forCancer EBG MedAustron GmbH
Testing effectiveness (Phase 2)Study completedNCT00005089What this trial is testingS0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 71